WuXi Biologics Earns EcoVadis Platinum Medal for Second Consecutive Year

• WuXi Biologics has received the EcoVadis Platinum Medal for sustainability for the second consecutive year.

• The company ranked in the top 1% of over 150,000 companies assessed globally for ESG performance.

WuXi Biologics has been awarded the Platinum Medal by the EcoVadis Sustainability Rating, marking its second consecutive year receiving the highest level of recognition. The rating evaluates companies on sustainability criteria, including Environment, Labour & Human Rights, Ethics, and Sustainable Procurement. In the latest assessment, WuXi Biologics ranked in the top 1% among more than 150,000 companies worldwide.

EcoVadis, a leading sustainability intelligence platform, assesses companies based on policies, actions, and results, incorporating input from third-party professionals and external stakeholders. The Platinum Medal highlights WuXi Biologics’ continued focus on environmental, social, and governance (ESG) excellence.

Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, stated, “We are very pleased to be once again recognized by EcoVadis with the Platinum Medal, which reflects our success in enhancing our sustainability capabilities.” He also emphasised the company’s role as a global leader in Green CRDMO and its commitment to enabling partners to achieve ESG goals.

The company actively participates in sustainability initiatives, including the United Nations Global Compact (UNGC) and the Pharmaceutical Supply Chain Initiative (PSCI). It has been recognised in multiple ESG indices, including the Dow Jones Sustainability Indices, FTSE4Good Index Series, and the Hang Seng ESG 50 Index. WuXi Biologics has also received an MSCI AAA rating and a CDP Water Security “A list” designation.